首頁 > 市場調查報告書 > 醫療設備

體外診斷感染疾病

市場調查報告書

商品編碼

1575016

梅毒免疫分析診斷市場，按測試類型、樣本類型、最終用戶、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Syphilis Immunoassay Diagnostic Market, By Test Type, By Sample Type, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日期: 2024年10月02日 | 出版商:

AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

報告要點

2023年梅毒免疫分析診斷市場規模為291,0932萬美元，2024年至2032年複合年成長率為7.60%。

梅毒免疫分析診斷市場-市場動態

對準確和快速診斷測試的需求激增推動梅毒免疫分析診斷市場的成長

對梅毒進行準確、快速的診斷測試的日益緊迫性極大地影響了免疫分析診斷市場。世界衛生組織報告稱，全球梅毒發病率上升，特別是在高風險族群中，凸顯了有效篩檢的必要性。創新的測試方法，例如即時檢測，可在 30 分鐘內提供結果，從而改善患者管理和治療結果。在美國，疾病管制與預防中心強調，從 2014 年到 2018 年，梅毒病例增加了近 75%，促使醫療保健提供者優先考慮快速檢測解決方案。性傳染感染的整體上升進一步推動了對可靠診斷測試的需求，導致主要醫療保健公司增加了研發投資。這一趨勢強調了快速診斷能力在控制梅毒傳播和改善公共衛生應變方面的關鍵作用。

梅毒免疫分析診斷市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032）每年將以 7.60% 左右的複合年成長率成長

根據測試類型細分，預計即時 (POC) 測試將在 2023 年顯示最大的市場佔有率

根據樣本類型細分，血液是2023年的主導類型

按地區分類，北美是 2023 年的主要收入來源

梅毒免疫分析診斷市場-細分分析：

全球梅毒免疫分析診斷市場根據測試類型、樣本類型、最終用戶和地區進行細分。

根據測試類型，市場分為四類：密螺旋體測試、非密螺旋體測試、照護端 (POC) 測試和自動免疫測定。由於即時檢測 (POC) 檢測快速且易於使用，預計將佔據主導地位。緊隨其後的是密螺旋體測試、非密螺旋體測試和自動免疫測定，每種測試在診斷方面都有獨特的優勢。

根據樣本類型，市場分為三類：血液、血清和血漿。由於血液樣本廣泛且易於採集，因此預計將領先。以下是血清樣本，因其在測試中的穩定性而受到青睞，以及血漿樣本，也常用於診斷。

梅毒免疫分析診斷市場-地理洞察

梅毒免疫分析診斷市場表現出顯著的地理差異，其中北美由於其先進的醫療基礎設施和性傳播感染的高盛行率而處於領先地位。疾病管制與預防中心注意到梅毒病例激增，促使採取措施加強篩檢和檢測能力。在歐洲，英國和德國等國家正在投資創新診斷技術，歐洲疾病預防與控制中心強調早期檢測和治療的重要性。在意識提高和醫療保健改善的推動下，亞太地區正在快速成長；例如，印度實施了國家計畫來解決高風險族群的梅毒篩檢問題。拉丁美洲也在取得進展，巴西報告了將快速診斷測試納入公共衛生策略的努力。同時，中東和非洲面臨獨特的挑戰，包括資源限制，但在旨在減輕性傳染感染負擔的國際衛生組織的推動下，它們開始採用更有效的檢測方法。

梅毒免疫分析診斷市場-競爭格局：

梅毒免疫分析診斷市場的競爭格局顯示了各個地區的重要活動。北美以雅培實驗室 (Abbott Laboratories) 和羅氏 (Roche) 等主要企業領跑，它們正在投資先進的免疫分析技術，以提高梅毒檢測的準確性和速度。美國性健康協會報告稱，快速檢測方法對於控制梅毒疫情至關重要。在歐洲，西門子醫療和生物梅里埃等公司正在歐盟改善性傳染感染檢測和治療方案措施的支持下推動創新。在亞太地區，Fujirebio 和 Tecan 等公司正在擴大其市場佔有率，其中日本和澳洲強調全面的篩檢計畫。拉丁美洲也正在成為一個競爭舞台，當地公司正在與國際公司合作，以改善獲得診斷測試的機會，這反映了世界衛生組織對減少梅毒盛行率的關注。在中東和非洲，在非政府組織旨在提高性健康意識的計劃的支持下，隨著價格實惠的檢測試劑盒的推出，市場正在不斷發展。

市場片段
- 梅毒免疫分析診斷市場片段（按測試類型）
- 按樣本類型分類的梅毒免疫分析診斷市場片段
- 最終用戶的梅毒免疫分析診斷市場片段
- 按國家/地區分類的梅毒免疫分析診斷市場片段
- 按地區分類的梅毒免疫分析診斷市場片段
競爭洞察

第 3 章：梅毒免疫分析診斷主要市場趨勢

梅毒免疫分析診斷市場促進因素
- 市場促進因素的影響分析
梅毒免疫分析診斷市場限制
- 市場限制影響分析
梅毒免疫分析診斷市場機會
梅毒免疫分析診斷市場未來趨勢

第 4 章：梅毒免疫分析診斷產業研究

PEST分析
波特五力分析
成長前景圖
規範架構分析

第 5 章：梅毒免疫分析診斷市場：COVID-19 影響分析

COVID-19 之前的影響分析
COVID-19 後影響分析
- 表現最佳的市場區隔
- 邊際成長市場區隔
- 最寬鬆的市場區隔
- 邊際損失市場區隔

第 6 章：梅毒免疫分析診斷市場格局

梅毒免疫分析診斷市佔率分析，2023 年
按主要製造商分類的故障數據
- 既有參與者分析
- 新興參與者分析

第 7 章：梅毒免疫分析診斷市場 - 按測試類型

概述
- 按測試類型分類的細分市場佔有率分析
- 密螺旋體測試
- 非密螺旋體測試
- 即時護理 (POC) 測試
- 自動免疫分析

第 8 章：梅毒免疫分析診斷市場 - 依樣本類型

概述
- 按樣本類型分類的細分市場佔有率分析
- 血
- 血清
- 電漿

第 9 章：梅毒免疫分析診斷市場 - 按最終用戶

概述
- 按最終用戶分類的細分市場佔有率分析
- 醫院
- 診斷實驗室
- 血庫
- 社區診所

第 10 章：梅毒免疫分析診斷市場 - 按地理位置

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美梅毒免疫分析診斷主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按測試類型）
- 北美市場規模和預測（按樣本類型）
- 北美市場規模和預測（按最終用戶）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲梅毒免疫分析診斷主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模和預測（按測試類型）
- 歐洲市場規模和預測（按樣本類型）
- 歐洲市場規模和預測（按最終用戶）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區梅毒免疫分析診斷主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模和預測（按測試類型）
- 亞太地區市場規模與預測（依樣本類型）
- 亞太地區市場規模和預測（按最終用戶）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲梅毒免疫分析診斷主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模和預測（按測試類型）
- 拉丁美洲市場規模和預測（按樣本類型）
- 拉丁美洲市場規模和預測（按最終用戶）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲梅毒免疫分析診斷主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按測試類型）
- 中東和非洲市場規模及預測（按樣本類型）
- 中東和非洲市場規模和預測（按最終用戶）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析-梅毒免疫分析診斷產業

競爭儀表板
公司簡介
- Abbott Laboratories
- Beckman Coulter, Inc.
- Becton, Dickinson and Company
- bioMerieux SA
- Bio-Rad Laboratories, Inc.
- Cardinal Health, Inc.
- Cepheid Inc. (Danaher)
- Chembio Diagnostics, Inc.
- DiaSorin SpA
- F. Hoffmann-La Roche AG
- Hologic, Inc.
- OraSure Technologies, Inc.
- Qiagen NV
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- Trinity Biotech plc
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法
參考
縮寫
免責聲明
聯絡我們

簡介目錄

Product Code: ANV4011

REPORT HIGHLIGHT

The Syphilis Immunoassay Diagnostic Market size was valued at USD 29,109.32 million in 2023, expanding at a CAGR of 7.60% from 2024 to 2032.

The Syphilis Immunoassay Diagnostic Market encompasses various testing methods used to detect syphilis infections, which remain a significant public health concern globally. With rising rates of syphilis, particularly among certain demographics, the demand for accurate and rapid diagnostic tests has surged. Increased awareness and education regarding sexually transmitted infections (STIs) have contributed to higher testing rates. Moreover, government initiatives aimed at reducing STI prevalence have bolstered market growth. However, challenges such as the availability of alternative testing methods and the stigma surrounding STIs may restrain market expansion. Opportunities lie in the development of novel immunoassay technologies and point-of-care testing solutions, which can enhance accessibility and facilitate timely treatment. For instance, the CDC reported a 20% increase in reported syphilis cases in recent years, highlighting the urgent need for improved diagnostic tools and public health interventions.

Syphilis Immunoassay Diagnostic Market- Market Dynamics

Surge in Demand for Accurate and Rapid Diagnostic Tests Propels Growth in the Syphilis Immunoassay Diagnostic Market

The growing urgency for accurate and rapid diagnostic tests for syphilis has significantly influenced the market for immunoassay diagnostics. The World Health Organization reported that global syphilis rates have risen, particularly among high-risk populations, underscoring the need for effective screening. Innovative testing methods, such as point-of-care tests, provide results in under 30 minutes, enhancing patient management and treatment outcomes. In the U.S., the Centers for Disease Control and Prevention highlighted that syphilis cases increased by nearly 75% from 2014 to 2018, prompting healthcare providers to prioritize swift testing solutions. The rise in sexually transmitted infections overall has further driven the demand for reliable diagnostic tests, leading to increased investments in research and development by major healthcare companies. This trend emphasizes the critical role of rapid diagnostic capabilities in controlling the spread of syphilis and improving public health responses.

Syphilis Immunoassay Diagnostic Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.60% over the forecast period (2024-2032)

Based on Test Type segmentation, Point-of-care (POC) Tests were predicted to show maximum market share in the year 2023

Based on Sample Type segmentation, Blood was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Syphilis Immunoassay Diagnostic Market- Segmentation Analysis:

The Global Syphilis Immunoassay Diagnostic Market is segmented on the basis of Test Type, Sample Type, End-User, and Region.

The market is divided into four categories based on Test Type: Treponemal Tests, Non-Treponemal Tests, Point-of-Care (POC) Tests, and Automated Immunoassays. Point-of-care (POC) Tests are predicted to dominate due to their rapid results and ease of use. Following closely are Treponemal Tests, Non-Treponemal Tests, and Automated Immunoassays, each offering unique benefits in diagnostics.

The market is divided into three categories based on Sample Type: Blood, Serum, and Plasma. Blood samples are expected to lead due to their widespread availability and ease of collection. Following are Serum samples, favored for their stability in testing, and Plasma samples, which are also commonly utilized in diagnostics.

Syphilis Immunoassay Diagnostic Market- Geographical Insights

The Syphilis Immunoassay Diagnostic Market exhibits significant geographical variation, with North America leading due to its advanced healthcare infrastructure and high prevalence of sexually transmitted infections. The Centers for Disease Control and Prevention noted a surge in syphilis cases, prompting initiatives to enhance screening and testing capabilities. In Europe, countries like the UK and Germany are investing in innovative diagnostic technologies, with the European Centre for Disease Prevention and Control emphasizing the importance of early detection and treatment. Asia-Pacific is witnessing rapid growth, driven by increasing awareness and healthcare improvements; for instance, India has implemented national programs to address syphilis screening among high-risk populations. Latin America is also making strides, with Brazil reporting efforts to integrate rapid diagnostic tests into public health strategies. Meanwhile, the Middle East and Africa face unique challenges, including resource constraints, but are beginning to adopt more effective testing methods, spurred by international health organizations aiming to reduce the burden of sexually transmitted infections.

Syphilis Immunoassay Diagnostic Market- Competitive Landscape:

The competitive landscape of the Syphilis Immunoassay Diagnostic Market showcases significant activity across various regions. North America leads with key players like Abbott Laboratories and Roche, which are investing in advanced immunoassay technologies to enhance accuracy and speed in syphilis testing. The American Sexual Health Association has reported that rapid testing methods are crucial in controlling syphilis outbreaks. In Europe, companies such as Siemens Healthineers and BioMerieux are driving innovation, supported by the European Union's initiatives to improve STI testing and treatment protocols. In the Asia-Pacific region, firms like Fujirebio and Tecan are expanding their market presence, with Japan and Australia emphasizing comprehensive screening programs. Latin America is also becoming a competitive arena, where local companies are partnering with international firms to improve access to diagnostic tests, reflecting the World Health Organization's focus on reducing syphilis prevalence. In the Middle East and Africa, the market is evolving with the introduction of affordable testing kits, supported by initiatives from non-governmental organizations to bolster sexual health awareness.

Recent Developments:

In August 2024, NowDiagnostics' First to Know(R) syphilis test received FDA de novo marketing authorization for over-the-counter use. This immunoassay diagnostic allows individuals to test for syphilis at home, enhancing accessibility and early detection of the infection.

In November 2021, MedAccess, CHAI, and SD Biosensor announced a partnership to provide a dual rapid test for syphilis and HIV for under $1 in over 100 low- and middle-income countries. This test enables quick diagnosis, improving maternal health and reducing stillbirths linked to syphilis.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Beckman Coulter, Inc.
Becton, Dickinson, and Company
bioMerieux S.A.
Bio-Rad Laboratories, Inc.
Cardinal Health, Inc.
Cepheid Inc. (Danaher)
Chembio Diagnostics, Inc.
DiaSorin S.p.A.
F. Hoffmann-La Roche AG
Hologic, Inc.
OraSure Technologies, Inc.
Qiagen N.V.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech plc
Others

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

Treponemal Tests
Non-Treponemal Tests
Point-of-Care (POC) Tests
Automated Immunoassays

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032

Blood
Serum
Plasma

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

Hospitals
Diagnostic Laboratories
Blood Banks
Community Clinics

GLOBAL SYPHILIS IMMUNOASSAY DIAGNOSTIC MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Syphilis Immunoassay Diagnostic Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Syphilis Immunoassay Diagnostic Market Snippet by Test Type
- 2.1.2. Syphilis Immunoassay Diagnostic Market Snippet by Sample Type
- 2.1.3. Syphilis Immunoassay Diagnostic Market Snippet by End-User
- 2.1.4. Syphilis Immunoassay Diagnostic Market Snippet by Country
- 2.1.5. Syphilis Immunoassay Diagnostic Market Snippet by Region
2.2. Competitive Insights

3. Syphilis Immunoassay Diagnostic Key Market Trends

3.1. Syphilis Immunoassay Diagnostic Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Syphilis Immunoassay Diagnostic Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Syphilis Immunoassay Diagnostic Market Opportunities
3.4. Syphilis Immunoassay Diagnostic Market Future Trends

4. Syphilis Immunoassay Diagnostic Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Syphilis Immunoassay Diagnostic Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Syphilis Immunoassay Diagnostic Market Landscape

6.1. Syphilis Immunoassay Diagnostic Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Syphilis Immunoassay Diagnostic Market - By Test Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Test Type, 2023 & 2032 (%)
- 7.1.2. Treponemal Tests
- 7.1.3. Non-Treponemal Tests
- 7.1.4. Point-of-Care (POC) Tests
- 7.1.5. Automated Immunoassays

8. Syphilis Immunoassay Diagnostic Market - By Sample Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Sample Type, 2023 & 2032 (%)
- 8.1.2. Blood
- 8.1.3. Serum
- 8.1.4. Plasma

9. Syphilis Immunoassay Diagnostic Market - By End-User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
- 9.1.2. Hospitals
- 9.1.3. Diagnostic Laboratories
- 9.1.4. Blood Banks
- 9.1.5. Community Clinics

10. Syphilis Immunoassay Diagnostic Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Syphilis Immunoassay Diagnostic Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Syphilis Immunoassay Diagnostic Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Syphilis Immunoassay Diagnostic Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Abbott Laboratories
- 11.2.2. Beckman Coulter, Inc.
- 11.2.3. Becton, Dickinson and Company
- 11.2.4. bioMerieux S.A.
- 11.2.5. Bio-Rad Laboratories, Inc.
- 11.2.6. Cardinal Health, Inc.
- 11.2.7. Cepheid Inc. (Danaher)
- 11.2.8. Chembio Diagnostics, Inc.
- 11.2.9. DiaSorin S.p.A.
- 11.2.10. F. Hoffmann-La Roche AG
- 11.2.11. Hologic, Inc.
- 11.2.12. OraSure Technologies, Inc.
- 11.2.13. Qiagen N.V.
- 11.2.14. Siemens Healthineers AG
- 11.2.15. Thermo Fisher Scientific Inc.
- 11.2.16. Trinity Biotech plc
- 11.2.17. Others